Quarterly report pursuant to Section 13 or 15(d)

11. Segment and Geographic Information (Tables)

v3.20.2
11. Segment and Geographic Information (Tables)
3 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Segment and Geographic Information

Note 11. Segment and Geographic Information

 

The Company generates product revenues from products which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services which are provided to medical device manufacturers.

 

The following table shows the Company’s product revenues by geographic region:

 

    Three Months Ended June 30,  
    2020     2019  
United States   $ 1,720,000     $ 2,487,000  
Latin America     2,320,000       654,000  
Europe and Rest of the World     3,214,000       1,244,000  
Total   $ 7,254,000     $ 4,385,000